Aqr Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.63 - $12.93 $13,637 - $26,597	-2,057 Reduced 14.39%	12,241 $86,000
Q1 2024 May 15, 2024	BUY	$8.04 - $16.03 $1,222 - $2,436	152 Added 1.07%	14,298 $196,000
Q4 2023 Feb 14, 2024	BUY	$5.41 - $9.43 $15,943 - $27,790	2,947 Added 26.31%	14,146 $130,000
Q3 2023 Nov 14, 2023	BUY	$6.05 - $9.28 $67,753 - $103,926	11,199 New	11,199 $67,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $33,771 - $88,431	12,508 New	12,508 $56,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $323M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.